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Allergic asthma as a complex outcome of pathogenic
immunological, cellular and functional modifications of
the airways is initiated by allergic reactions as a
response mostly to inhalant allergens. Dysregulation of
innate and adaptive immune functions contribute to the
pathogenesis of the disease. A hallmark is the develop-
ment of a Th2-driven inflammatory response in the air-
ways. The underlying Th2-skewed balance is the result
of a multi-functional process in which genetic predispo-
sition and environmental exposures interact as major
players. Maturation of the immune system already starts
in utero, the most critical phase in the ontogenetic pro-
gramming of the offspring. Endogenous as well as exo-
genous exposures may influence the maturation and
differentiation of immune cells of the fetus and may
thereby contribute to disorders such as allergies and
asthma later on in life. Epigenetic mechanisms are pro-
posed to mediate these effects. A comprehensive over-
view on the interaction of fetal exposures and the
developing immune system will be provided that may
contribute to or protect the progeny against the devel-
opment of asthma. The new and exciting field of epige-
netics will be highlighted with respect to T-cell
differentiation and early allergic disease development.
Furthermore, we emphasize new investigations that
aimed to analyze fetal host innate immune responses to
environmental microbial microorganisms and their pos-
sible future application in asthma protection.
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